▲ BUY
5
/ 10
Conviction
$ Value
$10K
Shares
10,000
Price
$1
Filed
Jan 22
▶ Why this score? (5/10)
- ✓ Open market buy (+3)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Agah Ramtin
Title
Chief Medical Officer
CIK
0001862617
Roles
Director
Officer
Transaction Details
Transaction Date
2026-01-21
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
798,460
Footnotes
Reflects open market purchases of the Issuer's securities. | Reflects a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $0.995 to $1.00.
Filing Info
Agah Ramtin's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-03 | RNXT | A | $0 |
| 2026-01-21 | RNXT | ▲ | $10K |
| 2025-12-31 | RNXT | ▲ | $8K |
| 2025-12-30 | RNXT | ▲ | $169 |
| 2025-12-16 | RNXT | ▲ | $10K |
| 2025-12-05 | RNXT | ▲ | $10K |
| 2025-11-24 | RNXT | ▲ | $10K |
| 2025-11-21 | RNXT | ▲ | $8K |
| 2025-07-01 | RNXT | A | $0 |
| 2025-06-05 | RNXT | ▲ | $29K ★ |
Other Insiders at RNXT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
VOLL MARK
Chief Financial Officer
|
— | — | 2026-04-03 |
| Marton Laurence | — | — | 2026-03-20 |
|
Bagai Shaun
Chief Executive Officer
|
— | — | 2026-04-03 |
|
Agah Ramtin
Chief Medical Officer
|
— | — | 2026-04-03 |
|
Gentry Leesa
Chief Clinical Officer
|
— | — | 2026-04-03 |